‘Immortalized’ Stem Cells Could Be the Key to Mass-Produced Artificial Blood – Gizmodo
Gizmodo |
‘Immortalized’ Stem Cells Could Be the Key to Mass-Produced Artificial Blood
Gizmodo Previously, researchers have been able to synthesize blood by isolating a type of stem cell that manufactures red blood cells and manipulating it to do its work in a lab. Unfortunately, the stem cells tend to become exhausted when they’ve produced … Immortal Stem Cells Let Scientists Create an Unlimited Supply of Artificial BloodScienceAlert “Immortalized” stem cells produce bigger, better blood batchesNew Atlas In Breakthrough Discovery, Scientists Mass-Produce Artificial BloodHuffington Post Geek Magazine –Wall Street Pit –I4U News –Nature all 22 news articles » |
Gizmodo |
Immortal Stem Cells Let Scientists Create an Unlimited Supply of Artificial Blood
ScienceAlert Researchers have developed a line immortal stem cells that allow them to generate an unlimited supply of artificial red blood cells on demand. If these artificial blood cells pass clinical trials, they’ll be far more efficient for medical use than … ‘Immortalized’ Stem Cells Could Be the Key to Mass-Produced Artificial BloodGizmodo “Immortalized” stem cells produce bigger, better blood batchesNew Atlas Global Stem Cell Umbilical Cord Blood Market 2017 : Cryosite, Stemlife, Smart Cells, LifeCell, CryolifeMedgadget (blog) Huffington Post –Geek Magazine –satPRnews (press release) –Nature all 32 news articles » |
上海科技 |
上海生科院利用CRISPR/Cpf1系统简单高效实现水稻多基因定点编辑
上海科技 3月19日，《分子植物》（Molecular Plant）杂志在线发表了中国科学院上海生命科学研究院植物逆境生物学研究中心朱健康研究组题为Multiplex Gene Editing in Rice using the CRISPR-Cpf1 System 的研究论文。该工作在水 … CRISPR专利故事跌宕起伏，这一次张锋输了……生物通 张锋团队这次输了？CRISPR/Cas9专利之争再起风云-搜狐搜狐 |
上海科技 |
上海生科院利用CRISPR/Cpf1系统简单高效实现水稻多基因定点编辑
上海科技 3月19日，《分子植物》（Molecular Plant）杂志在线发表了中国科学院上海生命科学研究院植物逆境生物学研究中心朱健康研究组题为Multiplex Gene Editing in Rice using the CRISPR-Cpf1 System 的研究论文。该工作在水 … CRISPR专利故事跌宕起伏，这一次张锋输了……生物通 张锋团队这次输了？CRISPR/Cas9专利之争再起风云搜狐 |
|
Could gene therapy, with help from California’s stem cell agency, treat ‘bubble boy disease’?
San Francisco Business Times Dr. Morton Cowan is the principal investigator of a gene therapy trial at UCSF that is… more. University of California Television. CIRM funding gives UCSF, St. Jude researchers a chance to show that combining gene therapy with a chemotherapy agent … |
|
Berkeley Team Gets European CRISPR Win After PTAB Loss
Law360 (subscription) In February, the team said the EPO announced its intention to grant them a patent covering CRISPR–CPf1. The institute said in a press release the technology “holds the potential for simpler and more precise genome engineering than has been available … |
Science Magazine |
Europe says University of California deserves broad patent for CRISPR
Science Magazine The European Patent Office (EPO) announced on 23 March its “intention to grant a patent” to the University of California (UC) for its broad-based claims about the genome-editing tool popularly known as CRISPR. UC, on behalf of several parties, has been … CRISPR Therapeutics Announces European Patent for CRISPR/Cas Gene EditingGlobeNewswire (press release) Chardan Capital Markets Starts CRISPR Therapeutics (CRSP) at BuyStreetInsider.com What’s the deal with CRISPR?McGill Tribune Reuters –Herald KS all 19 news articles » |
|
VIDEO: Intralesional agent, immunotherapy combination may increase response in metastatic melanoma
Healio NEW YORK — Robert H.I. Andtbacka, MD, CM, FACS, FRCSC, surgical oncologist at Huntsman Cancer Institute, and a HemOnc Today Editorial Board member, discussed the potential role of injectable immunotherapies and how they could change the tumor … |